Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir

Antiviral Research

Volumn 93, Issue 3, 2012, Pages 322-329

  Stoner, Terri D ^a   Krauss, Scott ^a   Turner, Jasmine C M ^a   Seiler, Patrick ^a   Negovetich, Nicholas J ^b   Stallknecht, David E ^c   Frase, Sharon ^a   Govorkova, Elena A ^a   Webster, Robert G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b ANGELO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Avian N6 subtype; Natural reservoir; Neuraminidase inhibitors; Oseltamivir; Resistance

Indexed keywords

MOLECULAR MARKER; OSELTAMIVIR;

ANTIVIRAL SUSCEPTIBILITY; ARTICLE; AVIAN INFLUENZA VIRUS; AVULAVIRUS; CONTROLLED STUDY; DUCKS AND GEESE; ELECTRON MICROSCOPY; FLUORESCENCE; GENE MUTATION; IN VITRO STUDY; NONHUMAN; POPULATION; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS TYPING;

ANIMALS; ANSERIFORMES; ANTIVIRAL AGENTS; ENZYME INHIBITORS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; MICROBIAL SENSITIVITY TESTS; NEURAMINIDASE; OSELTAMIVIR; VIRAL PROTEINS;

ANAS; ANATIDAE; AVES; AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE; PARAMYXOVIRIDAE;

EID: 84856256437     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.12.013     Document Type: Article

References (42)

1. Aoki F.Y., Boivin G., Roberts N.A. Influenza virus susceptibility and resistance to oseltamivir. Antivir. Ther. 2007, 12:603-616.
2. Baz M., Abed Y., McDonald J., Boivin G. Characterization of multidrug- resistant influenza A/H3N2 viruses shed during 1year by an immunocompromised child. Clin. Infect. Dis. 2006, 43(12):1555-1561.
3. Castrucci M.R., Donatelli I., Sidoli L., Barigazzi G., Kawaoka Y., Webster R.G. Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology 1993, 193(1):503-506.
4. Centers for Disease Control and Prevention (CDC), 2009. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009. MMWR Morb. Mortal. Wkly. Rep. 58, 969-972.
5. Cohen J. Swine flu outbreak new details on virus's promiscuous past. Science 2009, 324(5931):1127.
6. Collins P.J., Haire L.F., Lin Y.P., Liu J., Russell R.J., Walker P.A., Martin S.R., Daniels R.S., Gregory V., Skehel J.J., Gamblin S.J., Hay A.J. Structural basis for oseltamivir resistance of influenza viruses. Vaccine 2009, 27:6317-6323.
7. Deyde V.M., Sheu T.G., Trujillo A.A., Okomo-Adhiambo M., Garten R., Klimov A.I., Gubareva L.V. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob. Agents. Chemother. 2010, 54(3):1102-1110.
8. Fick J., Lindberg R.H., Tysklind M., Haemig P.D., Waldenström J., Wallensten A., Olsen B. Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus. PLoS One 2007, 2(10):e986.
9. Fouchier R.A., Munster V., Wallensten A., Bestebroer T.M., Herfst S., Smith D., Rimmelzwann G.F., Olsen B., Osterhaus A.D. Characterization of a novel influenza hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 2005, 79(5):2814-2822.
10. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A.M., Pappas C., Alpuche-Aranda C.M., López-Gatell H., Olivera H., López I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., St.George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
11. Ghosh G.C., Nakada N., Yamashita N., Tanaka H. Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants. Chemosphere 2010, 81(1):13-17.
12. Ghosh G.C., Nakada N., Yamashita N., Tanaka H. Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan. Environ. Health. Perspect. 2010, 118(1):103-107.
13. Govorkova E.A., Leneva I.A., Goloubeva O.G., Bush K., Webster R.G. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob. Agents. Chemother. 2001, 45:2723-2732.
14. Gubareva L.V., Penn C.R., Webster R.G. Inhibition of replication avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 1995, 212(2):323-330.
15. Gubareva L.V., Webster R.G., Hayden F.G. Activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob. Agents. Chemother. 2001, 45:3403-3408.
16. Gubareva L.V. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res. 2004, 103:199-203.
17. Hoffmann E., Stech J., Guan Y., Webster R.G., Perez D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 2001, 146:2275-2289.
18. Hurt A.C., Holien J.K., Barr I.G. In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimicrob. Agents Chemother. 2009, 53:4433-4440.
19. Kaverin N.V., Gambaryan A.S., Bovin N.V., Rudneva I.A., Shilov A.A., Khodova O.M., Varich N.L., Sinitsin B.V., Makarova N.V., Kropotkina E.A. Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology 1998, 244:315-321.
20. Kho C.L., Mohd-Azmi M.L., Arshad S.S., Yusoff K. Performance of an RT-nested PCR ELISA for detection of Newcastle disease virus. J. Virol. Methods 2000, 86(1):71-83.
21. Kim J.K., Negovetich N.J., Forrest H.L., Webster R.G. Ducks: the " Trojan horses" of H5N1 influenza. Influenza Other Respi. Viruses 2010, 3(4):121-128.
22. Krauss S., Walker D., Pryor S.P., Niles L., Chenhong L., Hinshaw V.S., Webster R.G. Influenza A viruses of wild migrating aquatic birds in North America. Vector Borne Zoonotic Dis. 2004, 4(3):177-189.
23. Krauss S., Obert C.A., Franks J., Walker D., Jones K., Seiler P., Niles L., Pryor S.P., Obenauer J.C., Naeve C.W., Widjaja L., Webby R.J., Webster R.G. Influenza in migratory birds and evidence of limited intercontinental virus exchange. PLoS Pathog. 2007, 3(11):e167.
24. Li Q., Qi J., Zhang W., Vavricka C.J., Shi Y., Wei J., Feng E., Shen J., Chen J., Liu D., He J., Yan J., Liu H., Jiang H., Teng M., Li X., Gao G.F. The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site. Nat. Struct. Mol. Biol. 2010, 17(10):1266-1268.
25. Miller P.J., Afonso C.L., Spackman E., Scott M.A., Pedersen J.C., Senne D.A., Brown J.D., Fuller C.M., Uhart M.M., Karesh W.B., Brown I.H., Alexander D.J., Swayne D.E. Evidence for a new avian paramyxovirus serotype 10 detected in rockhopper penguins from the Falkland Islands. J. Virol. 2010, 84(21):11496-11504.
26. Munster V.J., Wallensten A., Baas C., Rimmelzwaan G.F., Schutten M., Olsen B., Osterhaus A.D., Fouchier R.A. Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg. Infect. Dis. 2005, 11(10):1545-1551.
27. Munster V.J., Veen J., Olsen B., Vogel R., Osterhaus A.D., Fouchier R.A. Towards improved influenza A surveillance in migrating birds. Vaccine 2006, 24(44-46):6729-6733.
28. Orozovic G., Orozovic K., Lennerstrand J., Olsen B. Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds. PLoS One 2011, 6(1):e16028.
29. Palmer, D.F., Coleman, M.T., Dowdle, W.R., Schild, G.C., 1975. In: Advanced laboratory techniques for influenza diagnosis. Immunology Series No. 6. Procedural Guide, US Dept. of Health, Education and Welfare. p. 32.
30. Pizzorno A., Bouhy X., Abed Y., Boivin G. Generation and characterization of recombinant pandemic influenza A (H1N1) viruses resistant to neuraminidase inhibitors. J. Infect. Dis. 2011, 203(1):25-31.
31. Potier M., Mameli L., Bélisle M., Dallaire L., Melançon S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 1979, 94(2):287-296.
32. Russell R.J., Haire L.F., Stevens D.J., Collins P.J., Lin Y.P., Blackburn G.M., Hay A.J., Gamblin S.J., Skehel J.J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 2006, 443(7107):45-49.
33. Saccà M.L., Accinelli C., Fick J., Lindberg R., Olsen B. Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems. Chemosphere 2009, 75(1):28-33.
34. Singer A.C., Nunn M.A., Gould E.A., Johnson A.C. Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect. 2007, 115(1):102-106.
35. Söderström H., Järhult J.D., Olsen B., Lindberg R.H., Tanaka H., Fick J. Detection of the antiviral drug oseltamivir in aquatic environments. PLoS One 2009, 4(6):e6064.
36. Stoner T.D., Krauss S., DuBois R.M., Negovetich N.J., Stallknecth D.E., Senne D.A., Gramer M.R., Swafford S., DeLiberto T., Gorvokova E.A., Webster R.G. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype. J. Virol. 2010, 84(19):9800-9809.
37. Varghese J.N., Colman P.M. Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2•2å resolution. J. Mol. Biol. 1991, 221(2):473-486.
38. von Itzstein M., Wu Y.W., Kok G.B., Pegg M.S., Dyason J.C., Jin B., Van Phan T., Smythe M.L., White H.F., Oliver S.W., Colman P.M., Varghese J.N., Ryan D.M., Woods J.M., Bethell R.C., Hotham V.J., Cameron J.M., Penn C.R. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993, 363(6428):418-423.
39. Wagner R., Matrosovich M., Klenk H.D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 2002, 12(3):159-166.
40. Wang C., Miguel B., Austin F.W., Keirs R.W. Comparison of the immunofluorescent assay and reverse transcription-polymerase chain reaction to detect and type infectious bronchitis virus. Avian Dis. 1999, 43:590-596.
41. Warke A., Appleby L., Mundt E. Prevalence of antibodies to different avian paramyxoviruses in commercial poultry in the United States. Avian Dis. 2008, 52(4):694-697.
42. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses (review). Microbiol. Rev. 1992, 56(1):152-179.